Ian has a broad experience within the life science industry covering biotech, medtech and nutritional ingredients. He has been with DSM Venturing since 2008, investing in Europe, US and Israel. He is today more focused upon life science and material science investments within Europe and Israel. Ian has over 23 years’ experience in life science and technology driven companies, 17 years of which being within the pharmaceutical industry, addressing both innovative biotech companies as well as global pharma companies. He is currently a board member of Regentis, Essential Medical, Isobionics, NutriLeads, BioProcess Control, NovoPolymers and Arecor. Prior to joining DSM Venturing he ran an internal start-up which served both US West Coast and European biotech’s as well as major pharma companies with early stage clinical material. Before entering into venture capital Ian held various new business development, sales and B2B marketing positions.